Health insurance company Humana (NYSE: HUM) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know.
Humana beat analysts’ revenue expectations by 1.7% last quarter, reporting revenues of $32.39 billion, up 10.2% year on year. It was a strong quarter for the company, with a solid beat of analysts’ full-year EPS guidance estimates and full-year revenue guidance slightly topping analysts’ expectations. It added 3,200 customers to reach a total of 14.84 million.
Is Humana a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Humana’s revenue to grow 9.1% year on year to $31.97 billion, slowing from the 14.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.83 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Humana has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Humana’s peers in the health insurance providers segment, some have already reported their Q3 results, giving us a hint as to what we can expect. CVS Health delivered year-on-year revenue growth of 7.8%, beating analysts’ expectations by 4.1%, and Centene reported revenues up 18.2%, topping estimates by 3.7%. CVS Health traded down 6.7% following the results while Centene was up 5.5%.
Read our full analysis of CVS Health’s results here and Centene’s results here.
Investors in the health insurance providers segment have had steady hands going into earnings, with share prices flat over the last month. Humana is down 5.2% during the same time and is heading into earnings with an average analyst price target of $295.38 (compared to the current share price of $279.87).
P.S. In tech investing, "Gorillas" are the rare companies that dominate their markets—like Microsoft and Apple did decades ago. Today, the next Gorilla is emerging in AI-powered enterprise software. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
